Here’s what you should know.
1. Ms. Protopapas has more than 20 years healthcare experience.
2. She currently serves as the president and CEO of Cambridge, Mass.-based Mersana Therapeutics.
3. Bioverative CEO John Cox said, “Anna brings a proven track record of leading and growing biopharmaceutical companies, which will be extremely valuable as we work to deliver on our vision of building Bioverativ into a great rare disease company focused on blood disorders.”
More articles on improving health:
Only 31% of patients support surgeons performing overlapping surgeries: 4 things to know
20 US regions with the most & least medical debt
10 things to know about Regent Surgical Health
